The proprotein convertase, subtilisin/kexin type 5, or PCSK5, mediates post-translational endoproteolytic processing for several integrin α subunits. We identified two silent single-nucleotide polymorphisms (SNPs) in PCSK5, which were found to vary in frequency across ethnic groups. The identification of these amplification primers and SNPs provides tools to investigate PCSK5 for association with inflammatory or vascular phenotypes.
Introduction
Proprotein convertases are calcium-dependent serine proteases related to bacterial subtilisins and to yeast kexin (Seidah and Chretien 1999) . These enzymes process precursor proteins to their active forms by selective cleavage of the polypeptide at sites following paired basic amino acids. In mammals, this family comprises PCSK1, PCSK2, PCSK4, PCSK5, furin, and PACE4 (Seidah and Chretien 1999) . Substrates for these enzymes range from precursors for growth factors to cell surface receptors and viral surface glycoproteins. For instance, several integrin α subunits undergo post translational endoproteolytic processing at pairs of basic amino acids that is mediated by the proprotein convertase, subtilisin/kexin type 5, or PCSK5 (Lissitzky et al. 2000) . PCSK5 (OMIM #600488) encodes this proprotein convertase, which has been mapped to 9q21.3 (van de Loo et al. 1996) . We used our established approach (Cao and Hegele 2000) to develop amplification primers for PCSK5 coding sequences from genomic DNA and report the identification of two single-nucleotide polymorphisms (SNPs).
Methods

Study subjects
We screened genomic DNA from samples taken from 16 normal unrelated subjects. To estimate population frequencies of the PCSK5 SNPs, we screened 226 alleles from clinically normal subjects from various ethnic groups (66 Caucasian, 60 Chinese, and 50 each of African and Amerindian). The study was approved by the Ethics Review Panel, University of Western Ontario.
Screening the PCSK5 gene for DNA variants
To amplify coding regions and intron-exon boundaries from genomic DNA, we developed a primer set using GenBank sequences (see Table 1 ). Primer sequences were derived using GenBank accession numbers XM_011818 and 13641334. Primers were designed to anneal at a single temperature, which allowed for use of a single amplification apparatus. Amplification conditions were 94°C for 5 min, followed by 30 cycles of 30 s each at 94°C, 58°C, and 72°C, and ending with a single 10-min extension step at 72°C. Amplified fragments were purified and directly sequenced (ABI 377 Prism, ABI, Mississauga, ON, Canada).
Genotyping of PCSK5 gene SNPs
The PCSK5 1191G Ͼ A SNP was genotyped using amplification with primers for exon 3, as shown in Table 1 . The resulting fragment was 350 bp in length. Digestion of the 1191G allele with DdeI produced four fragments with length 221, 75, 31, and 23 bp, whereas digestion of the 1191A allele produced five fragments, with length 119, 102, 75, 31, and 23 bp. These fragments were resolved by electrophoresis in 2% agarose gels.
The PCSK5 2007C Ͼ T SNP was genotyped by amplification with primers for exon 9, as shown in Table 1 . The resulting fragment was 223 bp in length. Digestion of the 2007C allele with Alw21I produced two fragments with length 141 and 82 bp, whereas digestion of the 2007T allele produced one fragment, with length 223 bp. These fragments were resolved after electrophoresis in 2% agarose gels.
Statistical analysis SAS version 6.12 (SAS Institute, Cary, NC, USA) was used for statistical analyses. Allele frequencies were determined from electropheretogram tracings of genomic DNA sequence, except for two SNPs that were assayed using restriction digestion. Chi-square analysis tested the deviation of genotype frequencies from Hardy-Weinberg predictions. The nominal level of significance for statistical analyses was P Ͻ 0.05.
Results
SNP identification
Genomic DNA sequencing found two silent coding SNPs, designated PCSK5 1191G Ͼ A in exon 3, and 2007C Ͼ T in exon 9. No other variants were found.
SNP frequencies
The observed genotype frequencies of all SNPs did not deviate from Hardy-Weinberg expectations, and allele frequencies are shown in Table 2 . The PCSK5 exon 9 2007T allele was absent from Chinese and Amerindian study samples.
Discussion
We report (1) the definition of primer sets to amplify the coding sequences of the PCSK5 gene; and (2) the use of these amplification primers for genomic DNA sequencing, which has resulted in (3) the identification of two novel SNPs. The reagents described in this report could be helpful to screen the PCSK5 gene when it becomes a candidate for phenotypes that involve inflammation or the cardiovascular system, through positional cloning, analogy with other phenotypes, or expression data showing changes in response to particular experimental interventions. The SNPs could also be helpful in linkage mapping and for association studies. -ATT CTT ACC TTG TCT TTC CCC A -3Ј  260  R 5Ј-AAA GAT CAA GCT CTT TGT TTG TCA -3Ј  Exon 2  F 5Ј-TGA GTG ACG TTA TAA TTT GAC CTA TG -3Ј  227  R 5Ј-CTC TAT TTT GGG GCA TTG TCA T -3Ј  Exon 3  F 5Ј-TAT TTA TTC CAT GCC TCC AGG T -3Ј  350  R 5Ј-AGC AGC TGT TCC CTT CTA 
